DeutschNewstral
Article
bizjournals.com on 2015-10-22 18:23
FDA approves Cambridge biotech's pancreatic cancer drug
Related news
- FDA approves Cambridge biotech's first-ever drug for cancerbizjournals.com
- FDA approves local biotech's first rare-cancer drugbizjournals.com
- FDA warns public not to use Cambridge biotech's Covid-19 testbizjournals.com
- GSK pays $625M for Cambridge biotech's cancer antibodybizjournals.com
- FDA rejects Peninsula biotech's cancer drug — at least for nowbizjournals.com
- NFDA approves one-of-a-kind cancer gene testnypost.com
FDA approves test that quickly locates cancer genescantonrep.com
FDA approves groundbreaking cancer drugFOX 8 News Cleveland- FDA approves Teva cancer treatmentbizjournals.com
FDA Approves Teva’s Cancer DrugHaaretz
How barcoding technology could help Cambridge scientists fight pancreatic cancercambridgeindependent.co.uk
FDA approves first-of-a-kind test for cancer gene profiling - Fri, 01 Dec 2017 PSTThe Spokesman-Review
FDA approves first-of-a-kind test for cancer gene profilingocregister.com
FDA approves 2nd gene therapy for cancerCNN
FDA approves new kind of cancer treatmentWCPO
FDA approves a more 'personalized' cancer drugengadget- FDA approves Princeton pharma company's cancer drugbizjournals.com
FDA approves ACGT-funded cancer treatmentwestfaironline.com- MFDA approves Genentech's lung cancer drugmarketwatch.com